We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHS icon
901
Harte-Hanks
HHS
$16.2M
$47K ﹤0.01%
15,531
RFP
902
DELISTED
Resolute Forest Products Inc.
RFP
$47K ﹤0.01%
22,050
-2,950
-12% -$5.59K
ADMS
903
DELISTED
Adamas Pharmaceuticals
ADMS
$47K ﹤0.01%
18,375
+875
+5% +$2.57K
ARAY icon
904
Accuray
ARAY
$32M
$44K ﹤0.01%
21,685
-16,015
-42% -$33.3K
ODP
905
DELISTED
ODP
ODP
$44K ﹤0.01%
1,869
-2,681
-59% -$58.4K
ONDK
906
DELISTED
On Deck Capital, Inc.
ONDK
$44K ﹤0.01%
61,417
BGG
907
DELISTED
Briggs & Stratton Corp.
BGG
$43K ﹤0.01%
+32,913
New +$60.4K
CHS
908
DELISTED
Chicos FAS, Inc.
CHS
$41K ﹤0.01%
30,030
+1,430
+5% +$1.94K
PAEWW
909
DELISTED
PAE Incorporated Warrants
PAEWW
$39K ﹤0.01%
16,348
-21,504
-57% -$45.5K
VATE icon
910
INNOVATE Corp
VATE
$111M
$35K ﹤0.01%
1,050
-230
-18% -$6.5K
TLGT
911
DELISTED
Teligent, Inc
TLGT
$35K ﹤0.01%
14,396
-99
-0.7% -$349
FINV
912
FinVolution Group
FINV
$1.15B
$34K ﹤0.01%
+18,869
New +$31.4K
VERU icon
913
Veru
VERU
$36M
$34K ﹤0.01%
1,019
-231
-18% -$7.95K
AUD
914
DELISTED
Audacy, Inc.
AUD
$34K ﹤0.01%
24,438
ATRS
915
DELISTED
Antares Pharma, Inc.
ATRS
$31K ﹤0.01%
11,242
-26,756
-70% -$74.7K
RRD
916
DELISTED
RR Donnelley & Sons Co.
RRD
$31K ﹤0.01%
26,250
+1,250
+5% +$1.52K
CREXW
917
DELISTED
Creative Realities, Inc. Warrant
CREXW
$30K ﹤0.01%
12,236
-264
-2% -$103
TOVX icon
918
Theriva Biologics
TOVX
$9.64M
$29K ﹤0.01%
225
PR
919
Permian Resources
PR
$17.8B
$25K ﹤0.01%
+28,365
New +$24.9K
CSCI
920
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$19K ﹤0.01%
241
VIRX
921
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$13K ﹤0.01%
1,392
NOVN
922
DELISTED
Novan, Inc. Common Stock
NOVN
$5K ﹤0.01%
+1,000
New +$4.23K
AAPL icon
923
CALL
Apple
AAPL
$4.54T
-360
Closed -$2.29M
ABBV icon
924
CALL
AbbVie
ABBV
$443B
-113
Closed -$861K
ACAD icon
925
CALL
Acadia Pharmaceuticals
ACAD
$4.43B
-206
Closed -$870K

Similar funds

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.